Social Media for Arthritis-Related Comparative Effectiveness and Safety Research and the Impact of Direct-to-Consumer Advertising

The document discussed the use of social media for arthritis-related comparative effectiveness and safety research, highlighting its potential to provide real-time data and patient-reported outcomes that complement traditional clinical trials. It analyzed 785,656 social media posts, predominantly from the USA and authored by patients under 40, to assess the effectiveness and safety of medications like tofacitinib, etanercept, abatacept, and tocilizumab. The study found significant associations between tofacitinib and herpes zoster, alopecia, infections, and cancer, with a 91% positive predictive value for identifying herpes zoster cases. Direct-to-consumer advertising significantly influenced patient awareness and demand, leading to increased social media posts, mostly expressing safety concerns. The study concluded that social media could enhance drug safety research but should be interpreted cautiously.